“GRAS Associate (GA)’s team was highly professional, providing clear guidance appropriate tothe situation on the materials required for the submission. Their experts, with diversebackgrounds, offered valuable insights, particularly on safety considerations, ensuring ourapplication was robust and well-prepared. Additionally, GA's extensive experience incommunicating with the FDA was invaluable. They expertly managed amendments and guidedus through the complexities of the process with confidence and efficiency.” BTC Corporation (South Korea)

“Working closely with the dedicated Nutrasource team for this completed CuminUP60® GRAS affirmation opens the door for conventional food usage, like nutritional beverages, protein powders, sport and energy drinks, condiments and sauces, et al. We are excited about all the possibilities with CuminUP60®.” Chenland Nutritionals (China)

“The scientists at GRAS Associates did an excellent job pulling together all the sources of information to present a clear methodical assessment of the safety profile for our product. They also assembled a first rate peer review team to evaluate all the analysis and conclusions prior to sending it in to FDA. Once they provided it all to the FDA, they professionally dealt with any questions that came back and worked with me to provide the best answers possible. I would highly recommend GRAS Associates for similar applications to FDA.” Fresh Inset (USA)

“We are excited to receive the Letter of No Objection from the FDA to our Enzyme Modified Steviol Glycosides (EMSG) GRAS notification. The response underscores the safety of HOWTIAN's EMSG products, opening the opportunity to use them in a wide range of applications.” HOWTIAN (China)

“We are very excited to see Eriomin achieve self-GRAS status. The reception of this goes to show our continued investment and focus, as a leading manufacturer and supplier of citrus flavonoids, on developing and researching these beneficial ingredients.” IBN (USA)

“GRAS Associates was selected to prepare the GRAS dossier and notification to FDA due to having a higher than industry average success rate along with the expectation of smooth communication through Nutrasource Asia, which is based in Korea. Our expectations were correct, and we are pleased to say that this is the first GRAS notified strain to FDA as an oral probiotic in Korea. We believe this lays the foundation for entering the global market.” OraTicx (South Korea)